Sex differences in the association of sphingolipids with age in Dutch and South-Asian Surinamese living in Amsterdam, the Netherlands
Tóm tắt
Men have a higher risk for cardiovascular disease (CVD) early in life, while women have a higher risk later in life. The sex-related differences in CVD risk, especially by age, could be related to sphingolipid metabolism. We compared plasma sphingolipid concentrations and its increase by age in men and women. Plasma concentrations of 13 types of sphingolipids were measured by liquid chromatography-tandem mass spectrometry in a random subsample of 328 men and 372 women of Dutch and South-Asian Surinamese ethnic origin, participating in the HELIUS study. Sphingolipid concentrations were compared between men and women by age group (18–39, 40–55, and 56–70 years). Multiple linear regression was used to determine sex differences in age trends in sphingolipids stratified by ethnicity. Analyses were performed without adjustment and adjusted for body mass index (BMI) and waist circumference. At age 18–39 years, sphingolipid concentrations were lower in women than those in men, but at age 56–70 years this was reversed. At higher age, women showed higher concentrations than men. In line, we observed a more rapid increase of sphingolipid concentrations by age in women than in men. The observed sex differences were not explained by BMI or waist circumference. Patterns of sex differences were similar across ethnic groups, although the strength of associations differed. Mean sphingolipid concentrations increase more rapidly with age in women than in men. Therefore, plasma lipid concentrations of sphingolipids, although lower in women than in men at younger age, are higher in women than in men at older age.
Tài liệu tham khảo
World Health Organization. Noncommunicable diseases. 2018 https://www.who.int/en/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 12 Nov 2019.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210..
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England). 2010;375:9733:2215–22. https://doi.org/10.1016/s0140-6736(10)60484-9.
Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168(2):934–45. https://doi.org/10.1016/j.ijcard.2012.10.046..
Elbers JM, Asscheman H, Seidell JC, Gooren LJ. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol. 1999;276(2):E317–25. https://doi.org/10.1152/ajpendo.1999.276.2.E317..
Nordstrom A, Hadrevi J, Olsson T, Franks PW, Nordstrom P. Higher Prevalence of Type 2 Diabetes in men than in women Is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016;101(10):3740–6. https://doi.org/10.1210/jc.2016-1915.
Bairey Merz CN, Ramineni T, Leong D. Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real. Curr Opin Cardiol. 2018;33(5):500–5. https://doi.org/10.1097/hco.0000000000000543..
Hunter GR, Gower BA, Kane BL. Age related shift in visceral fat. Int J Body Compos Res. 2010;8(3):103–8.
Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19(3):175–91. https://doi.org/10.1038/nrm.2017.107..
Stiban J. Introduction: Enigmas of Sphingolipids. Adv Exp Med Biol. 2019;1159:1–3. https://doi.org/10.1007/978-3-030-21162-2_1..
Matanes F, Twal WO, Hammad SM. Sphingolipids as biomarkers of disease. Adv Exp Med Biol. 2019;1159:109–38. https://doi.org/10.1007/978-3-030-21162-2_7..
Borodzicz S, Czarzasta K, Kuch M, Cudnoch-Jedrzejewska A. Sphingolipids in cardiovascular diseases and metabolic disorders. Lipids Health Dis. 2015;14(1):55. https://doi.org/10.1186/s12944-015-0053-y.
Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016;37(25):1967–76. https://doi.org/10.1093/eurheartj/ehw148.
Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS. Plasma ceramides. Arterioscler Thromb Vasc Biol. 2018;38(8):1933–9. https://doi.org/10.1161/atvbaha.118.311199..
Uchida Y, Uchida Y, Kobayashi T, Shirai S, Hiruta N, Shimoyama E, et al. Detection of ceramide, a risk factor for coronary artery disease, in human coronary plaques by fluorescent angioscopy. Circ J. 2017;81(12):1886–93. https://doi.org/10.1253/circj.CJ-17-0363.
Edsfeldt A, Duner P, Stahlman M, Mollet IG, Asciutto G, Grufman H, et al. Sphingolipids contribute to human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol. 2016;36(6):1132–40. https://doi.org/10.1161/atvbaha.116.305675..
Cheng JM, Suoniemi M, Kardys I, Vihervaara T, de Boer SP, Akkerhuis KM, et al. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Atherosclerosis. 2015;243(2):560–6. https://doi.org/10.1016/j.atherosclerosis.2015.10.022..
Neeland IJ, Singh S, McGuire DK, Vega GL, Roddy T, Reilly DF, et al. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia. 2018;61(12):2570–9. https://doi.org/10.1007/s00125-018-4720-1.
Sui J, He M, Wang Y, Zhao X, He Y, Shi B. Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications. Exp Ther Med. 2019;18(5):3603–14. https://doi.org/10.3892/etm.2019.7981..
Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A, et al. Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2015;3(1):e000073. https://doi.org/10.1136/bmjdrc-2014-000073.
Zuellig RA, Hornemann T, Othman A, Hehl AB, Bode H, Guntert T, et al. Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. Diabetes. 2014;63(4):1326–39. https://doi.org/10.2337/db13-1042..
Jensen PN, Fretts AM, Yu C, Hoofnagle AN, Umans JG, Howard BV, et al. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: the Strong Heart Family Study. EBioMedicine. 2019;41:44–9. https://doi.org/10.1016/j.ebiom.2018.12.046..
Muilwijk M, SMI G, Celis-Morales C, Hof MH, Ghauharali-van der Vlugt K, Beers-Stet FS, et al. Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults. BMJ Open Diabetes Res Care. 2020;8(1):e001003. https://doi.org/10.1136/bmjdrc-2019-001003.
Choromańska B, Myśliwiec P, Razak Hady H, Dadan J, Myśliwiec H, Chabowski A, et al. Metabolic syndrome is associated with ceramide accumulation in visceral adipose tissue of women with morbid obesity. Obesity. 2019;27(3):444–53. https://doi.org/10.1002/oby.22405..
Brice SE, Cowart LA. Sphingolipid metabolism and analysis in metabolic disease. Adv Exp Med Biol. 2011;721:1–17. https://doi.org/10.1007/978-1-4614-0650-1_1..
Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, Völzke H, et al. Ceramide remodeling and risk of cardiovascular events and mortality. J Am Heart Assoc. 2018;7(10):e007931. https://doi.org/10.1161/JAHA.117.007931..
Park J-W, Park W-J, Futerman AH. Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim Biophys Acta. 2014;1841(5):671–81. https://doi.org/10.1016/j.bbalip.2013.08.019.
Chatterjee S, Bedja D, Mishra S, Amuzie C, Avolio A, Kass DA, et al. Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet. Circulation. 2014;129(23):2403–13. https://doi.org/10.1161/CIRCULATIONAHA.113.007559..
Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res. 2013;54(10):2898–908. https://doi.org/10.1194/jlr.P035808.
Mielke MM, Bandaru VV, Han D, An Y, Resnick SM, Ferrucci L, et al. Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species. Aging cell. 2015;14(6):1014–23. https://doi.org/10.1111/acel.12369..
Snijder MB, Galenkamp H, Prins M, Derks EM, Peters RJG, Zwinderman AH, et al. Cohort profile: the Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, The Netherlands. BMJ Open. 2017;7(12):e017873. https://doi.org/10.1136/bmjopen-2017-017873.
Stronks K, Snijder MB, Peters RJG, Prins M, Schene AH, Zwinderman AH. Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health. 2013;13:402. https://doi.org/10.1186/1471-2458-13-402.
Beukers MH, Dekker LH, de Boer EJ, Perenboom CW, Meijboom S, Nicolaou M, et al. Development of the HELIUS food frequency questionnaires: ethnic-specific questionnaires to assess the diet of a multiethnic population in The Netherlands. Eur J Clin Nutr. 2015;69(5):579–84. https://doi.org/10.1038/ejcn.2014.180..
Casetta B, Tagliacozzi D, Shushan B, Federici G. Development of a method for rapid quantitation of amino acids by liquid chromatography-tandem mass spectrometry (LC-MSMS) in plasma. Clin Chem Lab Med. 2000;38(5):391–401. https://doi.org/10.1515/cclm.2000.057..
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107. https://doi.org/10.1002/sim.3697.
Eastwood SV, Tillin T, Wright A, Heasman J, Willis J, Godsland IF, et al. Estimation of CT-derived abdominal visceral and subcutaneous adipose tissue depots from anthropometry in Europeans, South Asians and African Caribbeans. PloS one. 2013;8(9):e75085. https://doi.org/10.1371/journal.pone.0075085.
Spijkers LJ, van den Akker RF, Janssen BJ, Debets JJ, De Mey JG, Stroes ES, et al. Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PloS one. 2011;6(7):e21817. https://doi.org/10.1371/journal.pone.0021817.
Li G, Taljaard M, Van den Heuvel ER, Levine MAH, Cook DJ, Wells GA, et al. An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol. 2016;46(2):746–55. https://doi.org/10.1093/ije/dyw320..
Ishikawa M, Tajima Y, Murayama M, Senoo Y, Maekawa K, Saito Y. Plasma and serum from nonfasting men and women differ in their lipidomic profiles. Biol Pharm Bull. 2013;36(4):682–5. https://doi.org/10.1248/bpb.b12-00799..
Colleluori G, Chen R, Napoli N, Aguirre LE, Qualls C, Villareal DT, et al. Fat mass follows a U-shaped distribution based on estradiol levels in postmenopausal women. Front Endocrinol (Lausanne). 2018;9:315. https://doi.org/10.3389/fendo.2018.00315.
Samad F, Badeanlou L, Shah C, Yang G. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. Adv Exp Med Biol. 2011;721:67–86. https://doi.org/10.1007/978-1-4614-0650-1_5..
Kim HI, Kim JT, Yu SH, Kwak SH, Jang HC, Park KS, et al. Gender differences in diagnostic values of visceral fat area and waist circumference for predicting metabolic syndrome in Koreans. J Korean Med Sci. 2011;26(7):906–13. https://doi.org/10.3346/jkms.2011.26.7.906..
Vozella V, Basit A, Piras F, Realini N, Armirotti A, Bossù P, et al. Elevated plasma ceramide levels in post-menopausal women: a cross-sectional study. Aging (Albany NY). 2019;11(1):73–88. https://doi.org/10.18632/aging.101719.
Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med. 2017;21(5):1024–32. https://doi.org/10.1111/jcmm.13038..
Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med. 2006;26(4):847–70. https://doi.org/10.1016/j.cll.2006.07.006..
Hannun YA, Obeid LM. Many ceramides. J Biol Chem. 2011;286(32):27855–62. https://doi.org/10.1074/jbc.R111.254359..
Meeks KA, Freitas-Da-Silva D, Adeyemo A, Beune EJ, Modesti PA, Stronks K, et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. 2016;11(3):327–40. https://doi.org/10.1007/s11739-015-1302-9..
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. https://doi.org/10.1210/er.2015-1137.